Descriptor
| Clinical Diagnosis | 1 |
| Dementia | 1 |
| Drug Therapy | 1 |
| Molecular Biology | 1 |
| Neurological Impairments | 1 |
| Neuropsychology | 1 |
| Outcomes of Treatment | 1 |
| Psychopathology | 1 |
| Research Methodology | 1 |
| Sexually Transmitted Diseases | 1 |
Source
| Brain | 1 |
Author
| Fasano, A. | 1 |
| Latronico, T. | 1 |
| Lichtner, M. | 1 |
| Liuzzi, G. M. | 1 |
| Mastroianni, C. M. | 1 |
| Mengoni, F. | 1 |
| Riccio, P. | 1 |
| Vullo, V. | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Direct linkLiuzzi, G. M.; Mastroianni, C. M.; Latronico, T.; Mengoni, F.; Fasano, A.; Lichtner, M.; Vullo, V.; Riccio, P. – Brain, 2004
The introduction of potent antiretroviral drugs for the treatment of patients with human immunodeficiency virus (HIV) infection has dramatically reduced the prevalence of HIV-associated neurological disorders. Such diseases can be mediated by proteolytic enzymes, i.e. matrix metalloproteinases (MMPs) and, in particular gelatinases, released from…
Descriptors: Sexually Transmitted Diseases, Drug Therapy, Outcomes of Treatment, Dementia
